Life sciences companies regulated by the FDA and other authorities must conduct audits to ensure compliance, evaluate quality systems, and mitigate risks to product safety
An FDA warning letter highlights deficiencies in a medical device company’s CAPA quality data analysis procedures, emphasizing the critical need for robust, statistically justified trending
User-related errors in medical device use are a critical focus in risk analysis, where human factors engineering aims to minimize these errors through intuitive, user-centered
Data integrity in FDA-regulated industries is ensured by following Good Documentation Practices and ALCOA+ principles, which require records to be accurate, complete, attributable, and secure
The EU MDR requires manufacturers to develop and maintain comprehensive technical files that demonstrate a medical device’s compliance with safety, performance, and post-market surveillance requirements.
This guideline provides best practices for writing clear, effective, and compliant Standard Operating Procedures (SOPs) in pharmaceutical and medical device manufacturing. It covers authorship, structure,
This guideline highlights the importance of CAPA systems in pharmaceutical and medical device manufacturing to ensure regulatory compliance and product safety. It explains how CAPA
This document outlines a stability program to ensure drug product quality over time. It covers method validation, protocol development, shelf-life determination, and ongoing monitoring, following
Despite the long run up to preparations, it can still feel like you’re not prepared for EU MDR compliance. With the new MDR deadline rapidly
Conducting effective remote audits require a good deal of organization both before and during the audit to ensure adequate preparation of the audit team, effective